Sage Therapeutics, Inc. — Form D

Sage Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-24. The offering totals $38.0M, of which $38.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Jeffery M JonasDirectorCambridge, MA
Robert T NelsenDirectorChicago, IL
Steven T PaulDirectorCambridge, MA
Kevin T StarrDirectorCambridge, MA
Kimi M IguchiExecutive OfficerCambridge, MA
Jeffery M JonasExecutive OfficerCambridge, MA
Barry GreeneDirectorGrand Falls-Windsor, A4
Barry GreeneExecutive OfficerGrand Falls-Windsor, A4
Kimi IguchiExecutive OfficerCambridge, MA
Michael CloonanExecutive OfficerCambridge, MA
Anne Marie CookExecutive OfficerCambridge, MA
Stephen J KanesExecutive OfficerCambridge, MA
Albert J RobichaudExecutive OfficerCambridge, MA
Jeffrey M JonasDirectorCambridge, MA
Jeffrey M JonasExecutive OfficerCambridge, MA
Elizabeth F BarrettDirectorCambridge, MA
James F FratesDirectorCambridge, MA
Geno F GermanoDirectorCambridge, MA
George F GolumbeskiDirectorCambridge, MA
Steven F PaulDirectorCambridge, MA
Kevin P StarrDirectorCambridge, MA
Michael F ColaDirectorCambridge, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2021-01-15D$650.0M$650.0M
2014-01-21D$20.0M$10.0M

More